Old Web
English
Sign In
Acemap
>
Paper
>
P2.26 Budget Impact Analysis of Immunotherapy as Second-line Treatment of NSCLC at MX's National Institute of Cancer
P2.26 Budget Impact Analysis of Immunotherapy as Second-line Treatment of NSCLC at MX's National Institute of Cancer
2019
L.A. Ramírez-Tirado
Feliciano Barrón
L Zatarain-Barron
M.P. Peralta-Álvarez
Abelardo Meneses García
Luz María Ruiz Godoy
J De La Garza-salazar
D.I. Palafox Torres
M.F. Chávez Millan
J.A. Paladio-Hernandez
Andrés F. Cardona
Oscar Arrieta
Keywords:
Immunotherapy
General surgery
Medicine
Cancer
budget impact
second line treatment
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]